EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische Studie

Multicenter randomized trial comparing diagnostic sensitivity and cellular abundance with aggressive versus standard biliary brushing for bile duct stenosis without mass syndrome

David Karsenti iD, Jocelyn Privat, Aurélie Charissoux, Bastien Perrot, Sarah Leblanc, Ulriikka Chaput, Isabelle Boytchev, Jonathan Levy, Marion Schaefer, Jean-François Bourgaux, Jean-Christophe Valats, Emmanuel Coron und 5 weitere

Endoscopy · 01.09.2023 · 55 (09) · 796-803

DOI: 10.1055/a-2041-7687 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Endoscopy, erschienen am 01.09.2023. Verfasst von David Karsenti und 16 weiteren Autor:innen. Beteiligte Einrichtung: Digestive Endoscopy Unit, Pôle Digestif Paris Bercy, Clinique Paris-Bercy, France. Hauptthemen laut MEDLINE: Bile Duct Neoplasms, Cholangiocarcinoma, Cholestasis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The diagnosis of cholangiocarcinoma in patients with a biliary stricture without mass syndrome can be obtained by biliary brushing with a sensitivity of ~50 %. We performed a multicenter randomized crossover trial comparing the aggressive Infinity brush with the standard RX Cytology Brush. The aims were to compare sensitivity for cholangiocarcinoma diagnosis and cellularity obtained.

Methods

Biliary brushing was performed consecutively with each brush, in a randomized order. Cytological material was studied with blinding to the brush type used and order. The primary end point was sensitivity for cholangiocarcinoma diagnosis; the secondary end point was the abundance of cellularity obtained with each brush, with cellularity quantified in order to determine if one brush strongly outperformed the other.

Results

51 patients were included. Final diagnoses were cholangiocarcinoma (n = 43; 84 %), benign (n = 7; 14 %), and indeterminate (n = 1; 2 %). Sensitivity for cholangiocarcinoma was 79 % (34 /43) for the Infinity brush versus 67 % (29/43) for the RX Cytology Brush (P = 0.10). Cellularity was rich in 31/51 cases (61 %) with the Infinity brush and in 10/51 cases (20 %) with the RX Cytology Brush (P < 0.001). In terms of quantification of cellularity, the Infinity brush strongly outperformed the RX Cytology Brush in 28/51 cases (55 %), while the RX Cytology Brush strongly outperformed the Infinity brush in 4/51 cases (8 %; P < 0.001).

Conclusions

This randomized crossover trial showed that the Infinity brush is not significantly more effective than the RX Cytology Brush for biliary stenosis without mass syndrome in terms of sensitivity for cholangiocarcinoma diagnosis, but does offer a significantly higher abundance of cellularity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bile Duct NeoplasmsCholangiocarcinomaCholestasisSensitivity and SpecificityCholangiopancreatography, Endoscopic RetrogradeMyopiaMitral Valve ProlapseHumansBile Ducts, IntrahepaticConstriction, PathologicSkin Diseases

Autor:innen und Institutionen

  • Digestive Endoscopy Unit, Pôle Digestif Paris Bercy, Clinique Paris-Bercy, France.
  • Digestive Endoscopy Unit, Vichy Hospital Center, Vichy, France.
  • Department of Pathology, University Hospital Centre of Limoges, Limoges, France.
  • UMR 1246 SPHERE (MethodS in Patient-centered outcomes and HEalth ResEarch), INSERM, Nantes University, Tours University, France.
  • Digestive Endoscopy Unit, Jean Mermoz Private Hospital, Lyon, France.
  • Department of Digestive Diseases, Hôpital Saint-Antoine, Paris, France.

ORCID-Profile: David Karsenti, Geoffroy Vanbiervliet, Enrique Perez-Cuadrado Robles

Zitieren

APA

Karsenti, D., Privat, J., Charissoux, A., Perrot, B., Leblanc, S., Chaput, U., Boytchev, I., Levy, J., Schaefer, M., Bourgaux, J. F., Valats, J. C., Coron, E., Moreno-Garcia, M., Vanbiervliet, G., Rahmi, G., Robles, E. P., & Wallenhorst, T. (2023). Multicenter randomized trial comparing diagnostic sensitivity and cellular abundance with aggressive versus standard biliary brushing for bile duct stenosis without mass syndrome. Endoscopy, 55(09), 796-803. https://doi.org/10.1055/a-2041-7687

Vancouver

Karsenti D, Privat J, Charissoux A, Perrot B, Leblanc S, Chaput U, et al. Multicenter randomized trial comparing diagnostic sensitivity and cellular abundance with aggressive versus standard biliary brushing for bile duct stenosis without mass syndrome. Endoscopy. 2023;55(09):796-803. doi:10.1055/a-2041-7687

BibTeX
@article{Karsenti2023,
  author = {Karsenti, David and Privat, Jocelyn and Charissoux, Aurélie and Perrot, Bastien and Leblanc, Sarah and Chaput, Ulriikka and Boytchev, Isabelle and Levy, Jonathan and Schaefer, Marion and Bourgaux, Jean-François and Valats, Jean-Christophe and Coron, Emmanuel and Moreno-Garcia, Maira and Vanbiervliet, Geoffroy and Rahmi, Gabriel and Robles, Enrique Perez-Cuadrado and Wallenhorst, Timothée},
  title = {Multicenter randomized trial comparing diagnostic sensitivity and cellular abundance with aggressive versus standard biliary brushing for bile duct stenosis without mass syndrome},
  journal = {Endoscopy},
  year = {2023},
  volume = {55},
  number = {09},
  pages = {796--803},
  doi = {10.1055/a-2041-7687}
}
Kostenlos starten →